title: Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine.
abstract: In cultured cells, exposure to the nucleoside reverse transcriptase inhibitor (NRTI) zidovudine (AZT) induces genomic instability, cell cycle arrest, micronuclei, sister chromatid exchanges, and shortened telomeres. In previous studies, we demonstrated AZT-induced centrosome amplification (>2 centrosomes/cell). Here, we investigate centrosome amplification in cells exposed to other commonly used NRTIs. Experiments were performed using Chinese Hamster ovary (CHO) cells, and two normal human mammary epithelial cell (NHMEC) strains: M99005 and M98040, which are high and low incorporators of AZT into DNA, respectively. Cells were exposed for 24 hr to lamivudine (3TC), stavudine (d4T), didanosine (ddI), and thymidine, and stained with anti-pericentrin antibody. Dose response curves were performed to determine cytotoxicity and a lower concentration at near plasma levels and a 10 fold higher concentration were chosen for the experiments. In CHO cells, there was a concentration-dependent, significant (P < 0.05) increase in centrosome amplification for each of the NRTIs. In NHMEC strain M99005, an NRTI-induced increase (P < 0.05) in centrosome amplification was observed for the high concentrations of each NRTI and the low doses of 3TC and ddI. In NHMEC strain M98040, the high doses of ddI and d4T showed significant increases in centrosome amplification. Functional viability of amplified centrosomes was assessed by arresting microtubule nucleation with nocodazole. In cells with more than two centrosomes, the ability to recover microtubule nucleation was similar to that of unexposed cells. We conclude that centrosome amplification is a consequence of exposure to NRTIs and that cells with centrosome amplification are able to accomplish cell division.
authors: Laboratory of Cancer Biology and Genetics, National Cancer Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA.
authors: Mia
authors: M
authors: Yu
authors: Yvona
authors: Y
authors: Ward
authors: Miriam C
authors: MC
authors: Poirier
authors: Ofelia A
authors: OA
authors: Olivero
mesh_terms: D000818:Animals; D016466:CHO Cells; D018385:Centrosome; D006224:Cricetinae; D003412:Cricetulus; D016049:Didanosine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005784:Gene Amplification; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology; D008856:Microscopy, Fluorescence; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D018119:Stavudine / Q000494:pharmacology
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine; D016049:Didanosine